Development of Therapeutic Candidates for Biodefense, Antimicrobial Resistant (AMR) Infections and Emerging Infectious Diseases

NIH RePORTER · NIH · N01 · $2,475,623 · view on reporter.nih.gov ↗

Abstract

To support the advanced development of candidate therapeutics for biodefense pathogens or emerging infectious diseases. The supported research and development activities will progress the therapeutic product development and may include lead optimization, candidate selection, preclinical and IND enabling studies, Chemistry, Manufacturing, and Controls (CMC), IND submission, clinical safety and efficacy assessment.

Key facts

NIH application ID: 11178808
Project number: 75N93024C00008-0-9999-1
Recipient: GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT
Principal Investigator: NADER FOTOUHI
Activity code: N01
Funding institute: NIH
Fiscal year: 2024
Award amount: $2,475,623
Award type: —
Project period: 2024-05-10 → 2025-11-09